instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | DEXAMETHASONE, LEVOFLOXACIN, PEMBROLIZUMAB, PEMETREXED, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34646568 | 20,124,518 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | CARBOPLATIN, DEXAMETHASONE, LEVOFLOXACIN, PACLITAXEL, PEMBROLIZUMAB, PEMETREXED, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34646568 | 20,089,063 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | CARBOPLATIN, DEXAMETHASONE, PACLITAXEL, PEMBROLIZUMAB, PEMETREXED, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34646568 | 20,085,185 | 2021-11 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646568 | 20,109,208 | 2021-11 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | UNK, CYCLICAL, FIRST-LINE CHEMOTHERAPY | DrugDosageText | CC BY-NC-ND | 34646568 | 20,085,185 | 2021-11 |
What was the dosage of drug 'PEMETREXED'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | UNK, CYCLICAL, UNK, CYCLICAL, FIRST-LINE CHEMOTHERAPY | DrugDosageText | CC BY-NC-ND | 34646568 | 20,085,185 | 2021-11 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Fatal | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,085,185 | 2021-11 |
What was the outcome of reaction 'Atrial fibrillation'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,124,518 | 2021-11 |
What was the outcome of reaction 'Cardiac arrest'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,124,518 | 2021-11 |
What was the outcome of reaction 'Circulatory collapse'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Fatal | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,085,185 | 2021-11 |
What was the outcome of reaction 'Drug ineffective'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Fatal | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,109,208 | 2021-11 |
What was the outcome of reaction 'Hypotension'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,124,518 | 2021-11 |
What was the outcome of reaction 'Pneumonia legionella'? | Legionella pneumophila pneumonia with rapid clinical course in a lung cancer patient.
We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57-year-old man presented with fever and dyspnoea and was admitted to o... | Fatal | ReactionOutcome | CC BY-NC-ND | 34646568 | 20,124,518 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Persistent Raynaud's Phenomenon Following Methylphenidate Hydrochloride Use During the COVID-19 Pandemic.
Raynaud's phenomenon (RP) is a medical condition characterized by vasospasm of the digital vessels in the fingers and toes. The prevalence of RP in the general population is estimated at 3-5% and can vary based on ... | IBUPROFEN | DrugsGivenReaction | CC BY | 34646694 | 20,011,464 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicide attempt'. | Persistent Raynaud's Phenomenon Following Methylphenidate Hydrochloride Use During the COVID-19 Pandemic.
Raynaud's phenomenon (RP) is a medical condition characterized by vasospasm of the digital vessels in the fingers and toes. The prevalence of RP in the general population is estimated at 3-5% and can vary based on ... | IBUPROFEN | DrugsGivenReaction | CC BY | 34646694 | 20,011,464 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'SARS-CoV-2 test negative'. | Case of fatal eastern equine encephalitis.
Eastern Equine Encephalitis (EEE) is a rare and very serious arbovirus that is transmitted to humans through the bite of infected mosquitoes. When symptomatic, patients with this condition are typically seriously ill and the fatality rate is high. We present a fatal case of EE... | AMOXICILLIN, LEVETIRACETAM, LORAZEPAM | DrugsGivenReaction | CC BY-NC-ND | 34646732 | 20,092,532 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | Case of fatal eastern equine encephalitis.
Eastern Equine Encephalitis (EEE) is a rare and very serious arbovirus that is transmitted to humans through the bite of infected mosquitoes. When symptomatic, patients with this condition are typically seriously ill and the fatality rate is high. We present a fatal case of EE... | AMOXICILLIN, LEVETIRACETAM, LORAZEPAM | DrugsGivenReaction | CC BY-NC-ND | 34646732 | 20,092,532 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | CEFTAZIDIME, CEFTRIAXONE, CIPROFLOXACIN, DEXAMETHASONE, MEROPENEM, METFORMIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISOLONE, PREDNISOLONE ACETATE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34646733 | 20,117,886 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye infection'. | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | CEFTAZIDIME, CEFTRIAXONE, CIPROFLOXACIN, DEXAMETHASONE, MEROPENEM, METFORMIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISOLONE, PREDNISOLONE ACETATE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34646733 | 20,117,886 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye inflammation'. | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | CEFTAZIDIME, CEFTRIAXONE, CIPROFLOXACIN, DEXAMETHASONE, MEROPENEM, METFORMIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISOLONE, PREDNISOLONE ACETATE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE, VANCOMYCIN | DrugsGivenReaction | CC BY | 34646733 | 20,117,886 | 2021 |
What was the administration route of drug 'CEFTRIAXONE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34646733 | 20,117,886 | 2021 |
What was the administration route of drug 'CIPROFLOXACIN'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Oral | DrugAdministrationRoute | CC BY | 34646733 | 20,117,886 | 2021 |
What was the administration route of drug 'MEROPENEM'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34646733 | 20,117,886 | 2021 |
What was the administration route of drug 'METFORMIN HYDROCHLORIDE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Oral | DrugAdministrationRoute | CC BY | 34646733 | 20,117,886 | 2021 |
What was the administration route of drug 'PREDNISOLONE ACETATE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Ophthalmic | DrugAdministrationRoute | CC BY | 34646733 | 20,614,470 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Oral | DrugAdministrationRoute | CC BY | 34646733 | 20,117,886 | 2021 |
What was the administration route of drug 'PREDNISONE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Oral | DrugAdministrationRoute | CC BY | 34646733 | 20,614,470 | 2021 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | Oral | DrugAdministrationRoute | CC BY | 34646733 | 20,117,886 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | 400 MG/0.1 ML | DrugDosageText | CC BY | 34646733 | 20,117,886 | 2021 |
What was the dosage of drug 'MOXIFLOXACIN'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | 500 MG/0.1 ML | DrugDosageText | CC BY | 34646733 | 20,117,886 | 2021 |
What was the dosage of drug 'PREDNISOLONE ACETATE'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | UNK, EVERY HOUR | DrugDosageText | CC BY | 34646733 | 20,117,886 | 2021 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | 800MG/160MG, BID | DrugDosageText | CC BY | 34646733 | 20,117,886 | 2021 |
What was the dosage of drug 'VANCOMYCIN'? | A rare presentation of Klebsiella pneumoniae endogenous panophthalmitis with optic neuritis and orbital cellulitis from a urinary tract infection.
This case illustrates the rare presentation of endogenous Klebsiella pneumoniae endophthalmitis with concomitant orbital cellulitis from an acute pyelonephritis. A 59-year-o... | 1 MG/0.1 ML | DrugDosageText | CC BY | 34646733 | 20,117,886 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraplegia'. | Case Report: Systemic Treatment and Serial Genomic Sequencing of Metastatic Prostate Adenocarcinoma Progressing to Small Cell Carcinoma.
Small cell carcinoma (SCC)/neuroendocrine prostate cancer (NEPC) is a rare and highly aggressive subtype of prostate cancer associated with an AR(androgen receptor)-null phenotype and... | ABIRATERONE ACETATE, DOCETAXEL | DrugsGivenReaction | CC BY | 34646773 | 19,981,020 | 2021 |
What was the dosage of drug 'DOCETAXEL'? | Case Report: Systemic Treatment and Serial Genomic Sequencing of Metastatic Prostate Adenocarcinoma Progressing to Small Cell Carcinoma.
Small cell carcinoma (SCC)/neuroendocrine prostate cancer (NEPC) is a rare and highly aggressive subtype of prostate cancer associated with an AR(androgen receptor)-null phenotype and... | 75 MG/M2, QCY | DrugDosageText | CC BY | 34646773 | 19,981,020 | 2021 |
What was the outcome of reaction 'Paraplegia'? | Case Report: Systemic Treatment and Serial Genomic Sequencing of Metastatic Prostate Adenocarcinoma Progressing to Small Cell Carcinoma.
Small cell carcinoma (SCC)/neuroendocrine prostate cancer (NEPC) is a rare and highly aggressive subtype of prostate cancer associated with an AR(androgen receptor)-null phenotype and... | Recovering | ReactionOutcome | CC BY | 34646773 | 19,981,020 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain oedema'. | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | METHOTREXATE, PEGASPARGASE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | METHOTREXATE, PEGASPARGASE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
What was the administration route of drug 'METHOTREXATE'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 34646794 | 20,003,360 | 2021-07 |
What was the outcome of reaction 'Brain oedema'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
What was the outcome of reaction 'Encephalopathy'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
What was the outcome of reaction 'Febrile neutropenia'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
What was the outcome of reaction 'Headache'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
What was the outcome of reaction 'Nausea'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
What was the outcome of reaction 'Neurotoxicity'? | Cytotoxic Lesion in the Splenium of Corpus Callosum Secondary to Subacute Methotrexate Neurotoxicity.
Methotrexate neurotoxicity can present with a wide spectrum of neurologic symptoms and brain magnetic resonance imaging (MRI) typically demonstrates cerebral edema, demyelination, multifocal white matter necrosis, and ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646794 | 20,023,956 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chondropathy'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm malignant'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | ABATACEPT, ADALIMUMAB, CERTOLIZUMAB PEGOL, ETANERCEPT, GOLIMUMAB, RITUXIMAB, SECUKINUMAB, TOCILIZUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY | 34646840 | 20,653,492 | 2021 |
What was the administration route of drug 'GOLIMUMAB'? | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | Subcutaneous | DrugAdministrationRoute | CC BY | 34646840 | 20,653,492 | 2021 |
What was the administration route of drug 'USTEKINUMAB'? | Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Aims: To determine real-life biologic/targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD) retention rates in rheumatoid arthritis (RA), psoriatic arthritis ... | Subcutaneous | DrugAdministrationRoute | CC BY | 34646840 | 20,653,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemolytic anaemia'. | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | CIMETIDINE, DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34646843 | 20,453,235 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperbilirubinaemia'. | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | CIMETIDINE, DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34646843 | 20,453,235 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product misuse'. | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | CIMETIDINE, DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34646843 | 20,453,235 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver injury'. | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | CIMETIDINE, DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34646843 | 20,453,235 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal disorder'. | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | CIMETIDINE, DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34646843 | 20,453,235 | 2021 |
What was the administration route of drug 'CIMETIDINE'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Oral | DrugAdministrationRoute | CC BY | 34646843 | 20,453,235 | 2021 |
What was the administration route of drug 'DICLOFENAC SODIUM'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Oral | DrugAdministrationRoute | CC BY | 34646843 | 20,453,235 | 2021 |
What was the dosage of drug 'CIMETIDINE'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | 200 MG | DrugDosageText | CC BY | 34646843 | 20,453,235 | 2021 |
What was the dosage of drug 'DICLOFENAC SODIUM'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | 50 MG (SUSTAINED-RELEASE CAPSULE) | DrugDosageText | CC BY | 34646843 | 20,453,235 | 2021 |
What was the outcome of reaction 'Haemolytic anaemia'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Recovering | ReactionOutcome | CC BY | 34646843 | 20,453,235 | 2021 |
What was the outcome of reaction 'Hyperbilirubinaemia'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Recovered | ReactionOutcome | CC BY | 34646843 | 20,453,235 | 2021 |
What was the outcome of reaction 'Intentional product misuse'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Recovered | ReactionOutcome | CC BY | 34646843 | 20,453,235 | 2021 |
What was the outcome of reaction 'Liver injury'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Recovered | ReactionOutcome | CC BY | 34646843 | 20,453,235 | 2021 |
What was the outcome of reaction 'Renal disorder'? | Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while on... | Recovered | ReactionOutcome | CC BY | 34646843 | 20,453,235 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM).
Objectives: Infliximab (IFX) is widely used in patients with refractory Takayasu arteritis (TAK). Recently, the IFX-biosimilar CT-P13 has been introduced for the treatment of inf... | INFLIXIMAB | DrugsGivenReaction | CC BY | 34646844 | 19,992,608 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM).
Objectives: Infliximab (IFX) is widely used in patients with refractory Takayasu arteritis (TAK). Recently, the IFX-biosimilar CT-P13 has been introduced for the treatment of inf... | INFLIXIMAB | DrugsGivenReaction | CC BY | 34646844 | 19,992,608 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Takayasu^s arteritis'. | A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM).
Objectives: Infliximab (IFX) is widely used in patients with refractory Takayasu arteritis (TAK). Recently, the IFX-biosimilar CT-P13 has been introduced for the treatment of inf... | INFLIXIMAB | DrugsGivenReaction | CC BY | 34646844 | 19,992,608 | 2021 |
What was the administration route of drug 'INFLIXIMAB'? | A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM).
Objectives: Infliximab (IFX) is widely used in patients with refractory Takayasu arteritis (TAK). Recently, the IFX-biosimilar CT-P13 has been introduced for the treatment of inf... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34646844 | 19,992,608 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytopenia'. | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MESNA, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MESNA, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MESNA, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypersensitivity'. | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MESNA, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34646914 | 20,783,999 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm recurrence'. | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MESNA, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MESNA, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34646914 | 20,720,965 | 2021-12 |
What was the administration route of drug 'CARBOPLATIN'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
What was the administration route of drug 'CISPLATIN'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646914 | 20,778,737 | 2021-12 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646914 | 20,778,737 | 2021-12 |
What was the administration route of drug 'ETOPOSIDE'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646914 | 20,778,737 | 2021-12 |
What was the administration route of drug 'VINCRISTINE SULFATE'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646914 | 20,720,965 | 2021-12 |
What was the administration route of drug 'VINCRISTINE'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
What was the outcome of reaction 'Drug hypersensitivity'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
What was the outcome of reaction 'Hypersensitivity'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646914 | 20,783,999 | 2021-12 |
What was the outcome of reaction 'Neoplasm recurrence'? | An unusual case of late recurrence of bilateral retinoblastoma.
Recurrence of retinoblastoma usually occurs within the first few years after treatment. Despite complete tumor regression, delayed relapse of retinoblastoma can occur, predisposing patients to osteosarcoma as second malignancy. Our case was unique regardin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34646914 | 20,822,467 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspiration'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cough'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry mouth'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysgeusia'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspepsia'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphagia'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphonia'. | Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Concurrent chemoradiation plays an integral role in the treatment of esophageal cancer. Proton beam radiation therapy has the potential to spa... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 34646969 | 20,156,467 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.